Dermatology Flashcards
Acne vulgaris clinical manifestations
- Open comedones (blackheads): incomplete blockage
- Closed comedones (whiteheads): complete blockage
- Inflammatory: papules or pustules surrounded by inflammation
- Nodular or cystic: often heals w/scarring
Acne Vulgaris diagnosis
- Mild: comedones, small amounts of papules and/or pustules
- Moderate: comedones, larger amounts of papules and/or pustules
- Severe: nodular (>5mm) or cycstic acne
Acne Vulgaris treatment
- Comedones only: topical retinoid
- Papulopustular +/- comedones: topical retinoid + benzoyl peroxide
- Mild: topical - azelaic acid, salicyclic acid, benzoyl perozide, retinoids; tretinoin or topical abx (i.e. clindamycin or doxycycline)
- Moderate: as above + oral abx (i.e. minocycline or doxycycline)
- Severe (refractory or nodular acne): oral isotretinoin
Neonatal acne
- newborn to 8 weeks
- lesions limited to face
- responds to topical ketoconazole 2% cream
Isoretinoin
- most effective medication for acne vulgaris
- ADR: dry skin and lips (MC), hightly teratogenic, increased triglycerides and cholesterol
Rosacea triggers
- alcohol
- hot or cold weather
- hot drinks
- hot baths
- spicy foods
- sun exposure
Rosacea clinical manifestations
-Acne-like rash (papulopustules) and centrofacial erythema, facial flushing, telangiectasias, skin coarsening w/burning and stinging
Rosacea physical exam
- absence of comedones (blackheads)
- rhinophyma (red, enlarged nose)
Rosacea treatment
- mild-moderate: topical metronidazole 1st line, azelaic acid, topical ivermectin
- facial erythema: topical brimonidine
- clonidine for flushing
Folliculitis
- superficial hair follicle infection or inflammation
- etiology: staph aureus
- clinical manifestations: singular of clusters of perifollicular papules and/or pustules
- treatment: topical mupirocin
Erythema multiforme
type IV hypersensitivity reaction of the skin often following infections or medication exposure
Erythema multiforme risk factors
- herpes simplex virus MC, mycoplasma app. (esp in children)
- medications: sulfa drugs, beta-lactams, phenytoin, phenobarbital
Erythema multiforme clinical manifestations
- characterized by target lesions consisting of 3 components: a dusky, central area or blister, a dark red inflammatory zone surrounded by a pale ring of edema and an erythematous halo on the extreme periphery of the lesion
- negative nikolsky sign (no epidermal detachment)
- minor: target lesions with no mucosal membrane involvement
- major: target lesions with mucosal membrane involvement; no epidermal detachment
Erythema multiforme treatment
-symptomatic: discontinue offending drug, antihistamines, analgesics, skin care; corticosteroids + lidocaine + diphenhydramine mouthwash for oral lesions
Steven-Johnson Syndrome (SJS)
- severe mucocutaneous reaction characterized by detachment of the epidermis and extensive necrosis
- sloughing <10% body surface
Toxic Epidermal Necrolysis (TEN)
- severe mucocutaneous reactions characterized by detachment of the epidermis and extensive necrosis
- > 30% body surface area
SJS/TEN clinical manifestation
- prodrome of fever and URI sx’s followed by widespread flaccid bullae
- pruritic targetoid lesions (erythematous macules with purpuric centers) or diffuse erythema with involvement of at least 1 mucous membrane involvement with epidermal detachment (Nikolsky’s sign)
SJS/TEN treatment
- prompt discontinuation of causative agent
- supportive therapy: burn unit admission, pain control, fluid + electrolyte replacement, wound care
- IVIG for SJS
- no steroids fo SJS, lead to sepsis
- ophtho for TEN if eyes involved
- cyclosporine for severe TEN
SJS/TEN cause
sulfa drugs and anticonvulsants are MC cause
SJS/TEN diagnosis
clinical, biopsy* (shows full thickness skin necrosis/necrotic epithelium)